Full history for every metric is available with a Kvantra account

Stock profile
Medicover AB (publ) logo

Medicover AB (publ) (MCOV-B.ST)

Country: SwedenSector: HealthcareIndustry: Medical - Care FacilitiesExchange: STO
P/E TTM
40.0
History
P/E NTM
28.4
Market cap
39.67B
Currency SEK
KvantraRankAbout59
IValue69
IIQuality39
IIIMomentum70
Current price
261.00 SEK-0.76%
Close 13 Nov 2026
Interval
Benchmarks

Key financial summary

Financials in EUR
202020212022202320242025TTM2026E
Total revenue€m9981,3771,5101,7462,0922,3782,4472,437
Operating profit€m156182
Net profit€m26102121817789195
EPS reported€0.510.59
Operating cashflow per share€2.282.24
Capex per share€1.050.95
FCF per share€1.231.28
Free cash flow€m186195
Net debt€m792752
Book value equity€m533540
Book value per share€3.533.55
Number of sharesm150.98151.97
DPS (TTM paid)€0.200.20

Financial summary

Financials in EUR
202020212022202320242025TTM2026E
Value
P/E TTMx39.8340.00
P/B LTMx5.746.62
P/S LTMx1.291.46
P/FCF LTMx16.4818.31
EV/EBITDA LTMx11.6910.83
EV/Sales LTMx1.861.77
Earnings Yield LTM%2.51%2.50%
FCF Yield%6.07%5.46%
Quality
ROE%14.55%16.90%
ROIC%5.59%7.23%
Operating margin%6.55%7.45%
Gross margin%23.16%23.67%
FCF/Sales%7.80%7.97%
Growth and momentum
EPS Growth YoY%+363.64%+31.11%
Sales Growth YoY%+13.69%+5.07%
Net Income Growth YoY%+364.07%+34.92%
FCF Growth%+32.95%+25.88%
Operating Profit Growth%+121.48%+26.33%
Dividend and capital structure
Dividend Yield%0.74%0.86%
Dividend Growth%+36.65%+36.65%
Payout Ratio%29.22%33.74%
FCF/Debtx0.130.15
Net Debt/EBITDAx3.592.96
EBIT/Net interestx2.432.91
Net debt/market cap%25.90%21.06%
Net debt/Equityx1.491.39
Gross debt/equityx2.702.34

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ) is a prominent international provider of both healthcare and diagnostic services. The company operates across numerous countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It is structured into two main divisions: Healthcare Services and Diagnostic Services. Through its diagnostic division, Medicover performs a comprehensive array of specialized tests, which include analyses for allergy and autoimmune conditions; bacteriology and parasitology; biochemistry and immunochemistry; blood group diagnostics and transfusion medicine; tumour markers; clinical chemistry; cellular analyses like cytology, haematology, and histopathology; human genetics; hygiene; general immunology; infectious diseases; microbiology; molecular biology; and pharmacology/toxicology. Medicover maintains a substantial operational footprint, encompassing 97 clinical laboratories, 733 blood-drawing points, and 26 clinics dedicated to diagnostic services across 10 countries. Its healthcare segment further comprises 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. The company caters to a broad customer base, serving corporate entities, private individuals, direct patients, and public sector payers.

Trades inSEK

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Medicover AB (publ) (MCOV-B.ST)

MCOV-B.ST · STO · Healthcare
261.00 SEK-0.76%
Sign up to track this stock
Benchmarks
KvantraRank59
Market cap39.67B
P/E NTM28.4
P/E TTM40.0
KvantraRank?59 / 100
Value
69
Quality
39
Momentum
70
Financialsin EUR
20242025TTM2026E
Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

About

Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ) is a prominent international provider of both healthcare and diagnostic services. The company operates across numerous countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It is structured into two main divisions: Healthcare Services and Diagnostic Services. Through its diagnostic division, Medicover performs a comprehensive array of specialized tests, which include analyses for allergy and autoimmune conditions; bacteriology and parasitology; biochemistry and immunochemistry; blood group diagnostics and transfusion medicine; tumour markers; clinical chemistry; cellular analyses like cytology, haematology, and histopathology; human genetics; hygiene; general immunology; infectious diseases; microbiology; molecular biology; and pharmacology/toxicology. Medicover maintains a substantial operational footprint, encompassing 97 clinical laboratories, 733 blood-drawing points, and 26 clinics dedicated to diagnostic services across 10 countries. Its healthcare segment further comprises 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. The company caters to a broad customer base, serving corporate entities, private individuals, direct patients, and public sector payers.

IndustryMedical - Care Facilities
CountrySweden
Trades inSEK

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free